Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.54 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.51 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL872898 | 1.00 | HCAR2 (0.54) | HCAR2AKR1B10AKR1B1ESR1ESR2 | |
| SCHEMBL873497 | 1.00 | HCAR2 (0.54) | HCAR2AKR1B10AKR1B1ESR1ESR2 | |
| Propionic Acid SCHEMBL28726098 | 0.94 | HCAR2 (0.49) | HCAR2AKR1B10AKR1B1ESR1ESR2 | |
| Phenylacetic Acid SCHEMBL28249443 | 0.92 | AKR1B1 (0.50) | HCAR2AKR1B10AKR1B1ESR1ESR2 | |
| SCHEMBL28360113 | 0.90 | LMNA (0.58) | AKR1B10AKR1B1TDP1ALDH1A1NPC1 | |
| SCHEMBL3292422 | 0.87 | AKR1B10 (0.53) | HCAR2AKR1B10AKR1B1ESR1ESR2 | |
| SCHEMBL28186332 | 0.85 | HCAR2 (0.50) | HCAR2AKR1B10AKR1B1ESR1ESR2 | |
| SCHEMBL28363851 | 0.85 | HCAR2 (0.50) | HCAR2AKR1B10AKR1B1ESR1ESR2 | |
| SCHEMBL27952946 | 0.84 | HCAR2 (0.49) | HCAR2AKR1B10AKR1B1ESR1ESR2 | |
| SCHEMBL4676018 | 0.84 | HCAR2 (0.54) | HCAR2AKR1B10AKR1B1ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH & CIE (CH) | 2026-03-12 | — | — | US | claimed |
| US-20250129312-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2025-04-24 | — | — | US | claimed |
| CN-119768497-A | Treatment composition with perfume-containing delivery particles | 恩盖普有限公司 | 2025-04-04 | — | — | CN | claimed |
| US-12209232-B2 | Consumer product compositions with perfume encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2025-01-28 | — | — | US | claimed |
| CN-113873884-B | Arthropod control composition | 弗门尼舍有限公司 | 2024-06-14 | — | — | CN | claimed |
| US-20230340375-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2023-10-26 | — | — | US | claimed |
| EP-4257663-A1 | FOOD CONTACT SURFACE SANITIZING LIQUID | The Procter & Gamble Company (US) | 2023-10-11 | — | — | EP | claimed |
| US-11732222-B2 | Consumer product compositions with perfume encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2023-08-22 | — | — | US | claimed |
| US-20220142158-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2022-05-12 | — | — | US | claimed |
| US-20220142157-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH SA (CH) | 2022-05-12 | — | — | US | claimed |
| WO-2019165321-A1 | MOSCATO WINE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | AVA FOOD LABS, INC. (US) | 2019-08-29 | — | — | WO | claimed |
| WO-2019165323-A1 | ALCOHOLIC BEVERAGES PRODUCED FROM INDIVIDUAL COMPONENTS | AVA FOOD LABS, INC. (US) | 2019-08-29 | — | — | WO | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| EP-3197507-A1 | MALODOR REDUCTION COMPOSITIONS | The Procter and Gamble Company (US) | 2017-08-02 | — | — | EP | claimed |
| US-20160089464-A1 | MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049389-A1 | MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-7169746-B2 | Perfume composition | SHISEIDO CO., LTD. (JP) | 2007-01-30 | — | — | US | claimed |
| US-20060166857-A1 | 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes | SYMRISE GMBH & CO. KG (DE) | 2006-07-27 | — | — | US | claimed |
| US-20040242452-A1 | For effecting mental control through psycho-sedation or psycho-stimulation | SHISEIDO COMPANY, LTD. (JP) | 2004-12-02 | — | — | US | claimed |
| EP-1424071-A1 | PERFUME COMPOSITIONS | SHISEIDO COMPANY LIMITED (JP) | 2004-06-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | CNOT9, MSL1, MT-CO2 | HCAR2 3021/4885AKR1B10 2174/4885AKR1B1 2978/4885 |
| US-20220142157-A1 | ARTHROPOD CONTROLLING COMPOSITION | AGO2, NOP2, FBL | HCAR2 4701/4885AKR1B10 2564/4885AKR1B1 2842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.